Clinical Trial: Randomized, Placebo-controlled Trial Evaluating the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepharitis

U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07400965) titled 'Randomized, Placebo-controlled Trial Evaluating the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepharitis' on Feb. 03.

Brief Summary: This is a randomized, double-masked, placebo-controlled, dose-ranging, parallel-group, multi-center study designed to evaluate the safety and efficacy of GLK-321 in patients with Demodex blepharitis.

Study Start Date: Dec. 05, 2025

Study Type: INTERVENTIONAL

Condition: Demodex Blepharitis

Intervention: DRUG: GLK-321 low dose BID

Twice daily administration of low dose GLK-321 to both eyes

DRUG: GLK-321 mid dose BID

Twice daily administration of mid dose GLK-321 to both eyes

DRUG...